References
- Clayton JA. Dry eye. New England J Med. 2018;378:2212–23. doi:https://doi.org/10.1056/NEJMra1407936.
- Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539–74.
- Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo C-K, Liu Z, Nelson JD, Nichols JJ, Tsubota K, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–83. doi:https://doi.org/10.1016/j.jtos.2017.05.008.
- Rosenfield M. Computer vision syndrome: a review of ocular causes and potential treatments. Ophthalmic Physiol Opt. 2011;31:502–15. doi:https://doi.org/10.1111/j.1475-1313.2011.00834.x.
- Choi JH, Li Y, Kim SH, Jin R, Kim YH, Choi W, You IC, Yoon KC. The influences of smartphone use on the status of the tear film and ocular surface. PlosOne. 2018;13:e0206541. doi:https://doi.org/10.1371/journal.pone.0206541.
- Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112:71–82.
- Marshall LL, Roach JM. Treatment of dry eye disease. Consult Pharm. 2016;31:96–106. doi:https://doi.org/10.4140/TCP.n.2016.96.
- Gomes JAP, Azar DT, Baudouin C, Efron N, Hirayama M, Horwath-Winter J, Kim T, Mehta JS, Messmer EM, Pepose JS, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15(3):511–38.
- Mittal R, Vaezi MF. Esophageal motility disorders and gastroesophageal reflux disease. N Engl J Med. 2020;383(20):1961–197. doi:https://doi.org/10.1056/NEJMra2000328.
- Salihefendic N, Zidzic M, Cabric E. Laryngopharyngeal reflux disease – LPRD. Med Arch. 2017;71:215–18. doi:https://doi.org/10.5455/medarh.2017.71.215-218.
- Capagnolo AM, Priston J, Heidrichthoen R, Medeiros T, Assuncao RA. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2014;18:184–91.
- Koufman JA. Laryngopharyngeal reflux: position statement of the committee on speech, voice and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;217:32–35. doi:https://doi.org/10.1067/mhn.2002.125760.
- Francis DO, Rymer JA, Slaughter JC, Choksi Y, Jiramongkolchai P, Ogbeide E, Tran C, Goutte M, Garrett CG, Hagaman D, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108(6):905–11. doi:https://doi.org/10.1038/ajg.2013.69.
- Bulmer DM, Ali MS, Brownlee IA, Dettmar PW, Pearson JP. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope. 2010;120(4):777–82. doi:https://doi.org/10.1002/lary.20665.
- Adhami T, Goldblum JR, Richter JE, Vaezi MF. Role of gastric and duodenal ingredients in laryngeal tissue injury: an experimental study in dogs. Am J Gastroenterol. 2004;99:2098–106. doi:https://doi.org/10.1111/j.1572-0241.2004.40170.x.
- Johnston N, Wells CW, Samuels TL, Blumin JH. Pepsin in non-acid refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol. 2009;118:677–85. doi:https://doi.org/10.1177/000348940911800913.
- Gelardi M, Ciprandi G. Focus on gastroesophageal reflux (GER) and laryngopharyngeal reflux (LPR): new pragmatic insights in clinical practice. J Biol Regul Homeost Agents. 2018;32:41–47.
- Magliulo G, Plateroti R, Plateroti AM. Gastroesophageal reflux disease and the presence of pepsin in the tears. Med Hypotheses. 2013;80(2):129–30. doi:https://doi.org/10.1016/j.mehy.2012.11.008.
- Iannella G, Di Nardo G, Plateroti R, Rossi P, Plateroti AM, Mariani P, Magliulo G. Investigation of pepsin in tears of children with laryngopharyngeal reflux disease. Int J Pediatr Otorhinolaryngol. 2015;79(12):2312–15. doi:https://doi.org/10.1016/j.ijporl.2015.10.034.
- Mazzacane D, Damiani V, Silvestri M, Ciprandi G, Marino P. Eye reflux: an ocular extraesophageal manifestation of gastric reflux. Int J Ophthalmol. 2018;11:1503–07.
- Plateroti R, Sacchetti M, Magliulo G, Plateroti AM, Pace A, Moramarco A, Lambiase A, Bruscolini A. Evidence of pepsin-related ocular surface damage and dry eye (PROD syndrome) in patients with laryngopharyngeal reflux. Life. 2020;10:202. doi:https://doi.org/10.3390/life10090202.
- Schaumberg DA, Gulati A, Mathers WD, Clinch T, Lemp MA, Nelson JD, Foulks GN, Dana R. Development and validation of a short global dry eye symptom index. Ocul Surf. 2007;5:50–57. doi:https://doi.org/10.1016/S1542-0124(12)70053-8.
- Walt JG, Rowe MM, Stern KL. Evaluating the functional impact of dry eye: the ocular surface disease index. Drug Int J. 1997;31:1436.
- Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–21. doi:https://doi.org/10.1001/archopht.118.5.615.
- Pakdel F, Gohari MR, Jazayeri AS, Amani A, Pirmarzdashti N, Aghaee H. Validation of farsi translation of the ocular surface disease index. J Ophthalmic Vis Res. 2017;12(3):301–04. doi:https://doi.org/10.4103/jovr.jovr_92_16.
- Versura P, Frigato M, Bernabini B, Mulè R, Malavolta N, Campos EC. Ocular surface analysis in patients affected with rheumatic diseases. Reumatismo. 2004;56:262–71.
- Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, Pflugfelder SC. Minimally clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128:94–101. doi:https://doi.org/10.1001/archophthalmol.2009.356.
- O’Brien PD, Collum LM. Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep. 2004;4(4):314–19. doi:https://doi.org/10.1007/s11882-004-0077-2.
- Mengher LS, Bron AJ, Tonge SR, Gilbert DJ. A non-invasive instrument for clinical assessment of the pre-corneal tear film stability. Curr Eye Res. 1985;4:1–7. doi:https://doi.org/10.3109/02713688508999960.
- Stevens S. Schirmer’s test. Comm Eye Health. 2011;24:45.
- Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–50. doi:https://doi.org/10.1097/00003226-200310000-00008.
- Chun YS, Park IK. Reliability of 4 clinical grading systems for corneal staining. Am J Ophthalmol. 2014;157:1097–102. doi:https://doi.org/10.1016/j.ajo.2014.02.012.
- Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16(2):274–77. doi:https://doi.org/10.1016/S0892-1997(02)00097-8.
- Campagnolo AM, Priston J, Thoen RH, Medeiros T, Assunção AR. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2014;18:184–91.
- R Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2021. [accessed 2021 May 30]. https://www.R-project.org/.
- Reiter R, Heyduck A, Seufferlein T, Hoffmann T, Pickhard A. Laryngopharyngeal reflux. Laryngorhinootologie. 2018;97(4):238–45. doi:https://doi.org/10.1055/s-0044-100794.
- Runggaldier D, Hente J, Brockmann-Bauser M, Runggaldier D, Hente J, Brockmann-Bauser M, Pohl D, Bohlender JE. Current possibilities and challenges in the diagnosis of laryngopharyngealreflux]. HNO; 2021. (in press).
- Silva ÁS, Duprat AC, Machado SR, Melo DN, Nascimento Ribeiro DK. Evaluation of the reflux symptom index and the endolaryngeal findings scale after treatment in individuals with laryngopharyngeal reflux. Int Arch Otorhinolaryngol. 2021;25(1):e115–e122. doi:https://doi.org/10.1055/s-0040-1702967.
- Ciprandi G, Gelardi M. Gastric reflux: comparison between the gastroenterologist and the otorhinolaryngologist’s approach. Pragmatic conclusive remarks. J Biol Regul Homeost Agents. 2018;32:33–38.
- Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117:1036–39. doi:https://doi.org/10.1097/MLG.0b013e31804154c3.
- Kim Y, Lee Y, Cho YJ, Yoon HI, Lee JH, Lee CT, Park JS. Association between pepsin in bronchoalveolar lavage fluid and prognosis of chronic fibrosing interstitial lung disease. Tohoku J Exp Med. 2018;246:147–53. doi:https://doi.org/10.1620/tjem.246.147.
- Wang L, Tan JJ, Wu T, Zhang R, Wu JN, Zeng -F-F, Liu Y-L, Han X-Y, Li Y-F, Li X-P. Association between laryngeal pepsin levels and the presence of vocal fold polyps. Otolaryngol Head Neck Surg. 2017;156:144–51. doi:https://doi.org/10.1177/0194599816676471.
- Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg. 2009;141:559–63. doi:https://doi.org/10.1016/j.otohns.2009.08.022.
- Allen A, Pearson JP, Blackburn A, Coan RM, Hutton DA, Mall AS. Pepsins and the mucus barrier in peptic ulcer disease. Scand J Gastroenterol. 1988;23:50–57. doi:https://doi.org/10.3109/00365528809099130.
- Samuels TL, Handler E, Syring ML, Pajewski NM, Blumin JH, Kerschner JE, Johnston N. Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. Ann Otol Rhinol Laryngol. 2008;117:688–95. doi:https://doi.org/10.1177/000348940811700911.
- Balestrazzi A, Passali GC, Passali D, Damiani V, Ciprandi G, Balestrazzi E. A new therapeutic approach for the Dry Eye Syndrome in patients with laryngopharyngeal reflux: first data. Acta Biomed. 2020;91:36–42.
- Wan LQ, Jiang J, Arnold DE, Guo XE, Lu HH, Mow VC. Calcium concentration effects on the mechanical and biochemical properties of chondrocyte-alginate constructs. Cell Mol Bioeng. 2008;1:93–102. doi:https://doi.org/10.1007/s12195-008-0014-x.
- Davies I, Burman-Roy S, Murphy MS, Guideline Development Group. Gastroesophageal reflux disease in children: NICE guidance. BMJ. 2015;350:g7703. doi:https://doi.org/10.1136/bmj.g7703.
- Nacci A, Bastiani L, Barillari MR, Lechien JR, Martinelli M, de Bortoli N, Berrettini S, Assessment FB. Diagnostic accuracy evaluation of the reflux symptom index (RSI) scale: psychometric properties using optimal scaling techniques. Ann Otol Rhinol Laryngol. 2020;129(10):1020–29. doi:https://doi.org/10.1177/0003489420930034.